Alzheimer's disease
Neurodegeneration, biomarkers, and disease-modifying therapies.
- HARALD SONTHEIMER — UNIVERSITY OF VIRGINIA, VAExtracellular matrix and memory impairments in Alzheimer disease$709,066 · awarded Apr 7, 2026 · 5R01AG085359-03
- Keith Josephs — MAYO CLINIC ROCHESTER, MNThe neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies$643,670 · awarded Apr 1, 2026 · 5R01DC014942-09
- DMITRIY YABLONSKIY — WASHINGTON UNIVERSITY, MODeep-Learning-Augmented Quantitative Gradient Recalled Echo (DLA-qGRE) MRI for in vivo Clinical Evaluation of Brain Microstructural Neurodegeneration in Alzheimer Disease$661,985 · awarded Mar 3, 2026 · 4R01AG082030-02
- DAVID HOLTZMAN — WASHINGTON UNIVERSITY, MOAlzheimer's Disease Research Center$4,453,224 · awarded Mar 24, 2026 · 5P30AG066444-07
- HELENA CHUI — UNIVERSITY OF SOUTHERN CALIFORNIA, CAAlzheimer's Disease Research Centers$4,730,783 · awarded May 7, 2026 · 5P30AG066530-07